Adaptimmune GAAP EPS of -$0.02 beats by $0.07, revenue of $13.67M beats by $4.71M

* Adaptimmune press release [https://seekingalpha.com/pr/20199206-adaptimmune-reports-q2-financial-results-and-provides-business-update] (NASDAQ:ADAP [https://seekingalpha.com/symbol/ADAP]): Q2 GAAP EPS of -$0.02 beats by $0.07.
* Revenue of $13.67M (-89.3% Y/Y) beats by $4.71M.

MORE ON ADAPTIMMUNE

* SA Asks: Which oncology companies are attractive M&A targets? [https://seekingalpha.com/news/4452742-sa-asks-which-oncology-companies-are-attractive-ma-targets]
* Seeking Alpha’s Quant Rating on Adaptimmune [https://seekingalpha.com/symbol/ADAP/ratings/quant-ratings]
* Historical earnings data for Adaptimmune [https://seekingalpha.com/symbol/ADAP/earnings]
* Financial information for Adaptimmune [https://seekingalpha.com/symbol/ADAP/income-statement]